Table 1 Univariate and multivariate analyses of factors associated with overall survival of GC patients (n = 116).

From: Mortalin/glucose-regulated protein 75 promotes the cisplatin-resistance of gastric cancer via regulating anti-oxidation/apoptosis and metabolic reprogramming

Clinical variables

Overall survival

HR (95% Cl)

p-value

Univariate analysis

 Age (≤60 vs. >60)

1.471 (0.883 to 2.449)

0.183

 Gender (male vs. female)

1.019 (0.569 to 1.829)

0.950

 Tumor size (≤5 cm vs. >5 cm)

1.997 (1.193 to 3.344)

0.009

 Differentiation (well vs. poor)

2.002 (1.151 to 3.482)

0.014

 Vascular invasion (negative vs. positive)

1.458 (0.822 to 2.584)

0.197

 pTNM stage (I/II vs. III)

3.248 (1.594 to 6.617)

<0.0001

 GRP75 (low vs. high)

2.817 (1.646 to 4.821)

<0.0001

Multivariate analysis

 pTNM stage (I/II vs. III)

2.221 (1.016 to 4.855)

0.045

 GRP75 (low vs. high)

2.075 (1.151 to 3.740)

0.015

  1. All patients were received platinum-based chemotherapy.